Skip to main content

View full-text article in PMC

. 2006 Jan 23;147(6):587–595. doi: 10.1038/sj.bjp.0706669

Table 1.

Selected morphometric parameters following 4 weeks of daily formoterol administration (n=8 rats dose⁻¹)

		Dose (μg kg⁻¹)
	Control (vehicle)	1	10	25	250	500	1000	2000
Final BM (g)	298±4	320±6^*	325±5^*	315±5^*	313±3^*	318±3^*	311±4^*	307±3
EDL mass (mg)	104±1	117±2^*	133±2^*^†	128±2^*	133±1^*^†	141±1^*^†	135±2^*	134±1^*
EDL mass/BM	0.35±0.01	0.42±0.01^*	0.41±0.01^*	0.40±0.01^*	0.43±0.01^*^†	0.44±0.01^*	0.44±0.01^*	0.44±0.01^*
Soleus mass (mg)	94±1	105±2^*	106±1^*	107±2^*	109±2^*	118±2^*^†	110±2^*	108±2^*
Soleus mass/BM	0.31±0.01	0.34±0.01^*	0.32±0.01	0.34±0.01^*	0.35±0.01^*	0.37±0.01^*^†	0.35±0.01^*	0.35±0.01^*
Heart mass (mg)	661±12	693±14	751±10^*^†	748±19^*	807±16^*^†	830±17^*	802±9^*	821±9^*
Heart mass/BM	2.22±0.03	2.16±0.02	2.31±0.03^*^†	2.36±0.02^*	2.58±0.05^*^†	2.61±0.05^*	2.58±0.02^*	2.68±0.03^*^†

BM: body mass, EDL: extensor digitorum longus

^*

P<0.05 treated vs respective control

^†

P<0.05 significantly different from previous (lower) dose. Results presented as mean±s.e.m.